Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Eleven Bio Inc (EBIO)

Eleven Bio Inc (EBIO)
3.29 +0.64 (+24.15%) 05/16/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Wed, May 16th, 2018
Day Low
2.73
Day High
3.44
Open 2.74
Previous Close 2.65 2.65
Volume 15,611,300 15,611,300
Avg Vol 7,990,690 7,990,690
Stochastic %K 60.59% 60.59%
Weighted Alpha +35.90 +35.90
5-Day Change +0.46 (+16.25%) +0.46 (+16.25%)
52-Week Range 0.62 - 3.50 0.62 - 3.50
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 157,229
  • Shares Outstanding, K 47,790
  • Annual Sales, $ 430 K
  • Annual Income, $ -29,030 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.75
  • Price/Sales 297.98
  • Price/Cash Flow N/A
  • Price/Book 6.58
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.89
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/17/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +56.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.42 +131.69%
on 04/18/18
Period Open: 1.58
3.50 -6.00%
on 05/02/18
+1.71 (+108.23%)
since 04/16/18
3-Month
0.90 +265.56%
on 03/02/18
Period Open: 0.93
3.50 -6.00%
on 05/02/18
+2.37 (+255.68%)
since 02/16/18
52-Week
0.62 +430.65%
on 11/10/17
Period Open: 1.64
3.50 -6.00%
on 05/02/18
+1.65 (+100.61%)
since 05/16/17

Business Summary

Eleven Biotherapeutics, Inc. is engaged in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States. The company develops its therapeutics through AMP-Rx, a proprietary protein engineering platform. Its principal preclinical product candidate consist...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 3.86
1st Resistance Point 3.58
Last Price 3.29
1st Support Level 2.87
2nd Support Level 2.44
3rd Support Level N/A

See More

52-Week High 3.50
Last Price 3.29
Fibonacci 61.8% 2.40
Fibonacci 50% 2.06
Fibonacci 38.2% 1.72
52-Week Low 0.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro